| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.7M | +71.6% |
| Cost of Revenue | $8.3M | +86.0% |
| Gross Profit | $1.3M | +15.8% |
| R&D Expense | $559K | +89.3% |
| SG&A Expense | $12.0M | +52.2% |
| Operating Income | -$10.7M | -58.5% |
| Pre-tax Income | -$6.2M | +53.7% |
| Income Tax | $150 | +109.7% |
| Net Income | -$6.2M | +53.7% |
| EPS (Basic) | -$1.13 | +94.6% |
| EPS (Diluted) | -$1.13 | +94.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | +442.2% |
| Accounts Receivable | $719K | +17.3% |
| Inventory | $2.9M | -40.8% |
| Current Assets | $7.0M | -10.2% |
| Total Assets | $8.1M | -11.4% |
| Current Liabilities | $997K | -83.0% |
| Long-term Debt | $197K | -14.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | +35.7% |
| Investing Cash Flow | $4K | -96.3% |
| Financing Cash Flow | $8.6M | +41.3% |
| $1.5M |
| -76.7% |
| Stockholders' Equity | $6.5M | +159.5% |